Baupost Group Drops Targacept While SAC Buys AmarinVW Staff
Several major investors made moves in the pharmaceuticals arena last week as the ups and downs in that industry came to the fore. The Baupost Group sold off its entire holdings of the Biotechnology firm Targacept Inc. (NASDAQ:TRGT) and SAC Capital advisers continued to increase its stake in the pharmaceuticals research firm Amarin Corporation plc (NYSE:AMRN). Both pieces of news . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.